Embargoed until 7 a.m. Pacific Time 10 a.m. Eastern Time, Thursday, Jan. 25, 2018
LOS ANGELES, Jan. 25, 2018 — Clot removal may be beneficial up to 24 hours following stroke in carefully selected patients, but every hour delayed after symptoms begin may be associated with more disability, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.
The international DAWN trial previously demonstrated that patients with a small area of irreversible brain damage and a large area of brain at jeopardy of being lost if the clot remains are more likely to recover with minimal disability if the clot is removed up to 24 hours after symptoms begin or were noticed. It is already well-established that the benefit of clot removal declines each hour during the first 6 hours after symptoms are detected.
In the current analysis of treatment between 6 and 24 hours after symptoms were observed, or after the person was last seen to be well, researchers found:
each 1-hour delay reduces the chance of recovery with minimal or no disability by 11 percent; and
treatment remains beneficial through 24 hours, with patients who had their clots removed being 35.5 percent more likely to have minimal or no disability 90 days later, but the overall effect of treatment declines with time.
The current results demonstrate the importance of prompt imaging and treatment of patients with clot-caused stroke, even in those who wake up having experienced a stroke or who for other reasons are not identified in the first few hours after the onset of symptoms.
Stryker Neuroendovascular funded the DAWN Trial.
Raul G. Nogueira M.D., Emory University School of Medicine, Atlanta, Georgia.
Presentation location: Room 151
- Available downloadable B-roll, animation and images to this news tip are on the right column of the tip link https://newsroom.heart.org/news/prompt-clot-grabbing-treatment-produces-better-stroke-outcomes?preview=827d0c5c4976829ca42b217851413700
- For more news at AHA International Stroke Conference 2018, follow us on Twitter @HeartNews #ISC18.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit StrokeAssociation.org. Follow us on Facebook and Twitter.
For Media Inquiries and AHA Spokesperson Perspective:
AHA News Media in Dallas: 214-706-1173
AHA News Media Office, Jan. 24-26, 2018 at the Los Angeles Convention Center: 213-743-6262
For Public Inquiries: 800-AHA-USA1 (242-8721)